EPS for R1 RCM Inc (RCM) Expected At $-0.03

October 13, 2017 - By wolcottdaily

 EPS for R1 RCM Inc (RCM) Expected At $ 0.03

Wall Street await R1 RCM Inc (NASDAQ:RCM) to release earnings on November, 1. Analysts forecast EPS of $-0.03, down exactly $0.21 or 116.67 % from 2014’s $0.18 EPS. After posting $-0.11 EPS for the previous quarter, R1 RCM Inc’s analysts now forecast -72.73 % EPS growth. The stock increased 1.15% or $0.04 during the last trading session, reaching $3.53. About 385,969 shares traded or 61.97% up from the average. R1 RCM Inc (NASDAQ:RCM) has 0.00% since October 13, 2016 and is . It has underperformed by 16.70% the S&P500.

R1 RCM Inc., formerly Accretive Health, Inc., is a well-known provider of revenue cycle management and physician advisory services (PAS) to healthcare providers. The company has market cap of $366.07 million. The Firm is engaged in providing management services of revenue cycle activities for the United States hospitals and other medical services providers. It currently has negative earnings. The Company’s primary service offering consists of end-to-end RCM, which the Company deploys through a co-managed relationship or an operating partner relationship.

More notable recent R1 RCM Inc (NASDAQ:RCM) news were published by: Seekingalpha.com which released: “R1 RCM’s (ACHI) CEO Joe Flanagan on Q4 2016 Results – Earnings Call Transcript” on March 02, 2017, also Seekingalpha.com with their article: “R1 RCM’s (RCM) CEO Joseph Flanagan on Q1 2017 Results – Earnings Call Transcript” published on May 10, 2017, Chicagobusiness.com published: “After years of turmoil, Accretive Health ditches name” on January 06, 2017. More interesting news about R1 RCM Inc (NASDAQ:RCM) were released by: Seekingalpha.com and their article: “R1 RCM’s (RCM) CEO Joseph Flanagan on Q2 2017 Results – Earnings Call Transcript” published on August 03, 2017 as well as Globenewswire.com‘s news article titled: “Intermountain Healthcare Selects R1 for Revenue Capture Modular Solution” with publication date: October 05, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.